Ignite Creation Date:
2025-12-26 @ 10:43 PM
Ignite Modification Date:
2026-03-01 @ 8:11 PM
Study NCT ID:
NCT04101812
Status:
UNKNOWN
Last Update Posted:
2019-09-26
First Post:
2019-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer
Sponsor:
Tianjin Medical University Second Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-17
First Submit QC Date:
None
Study First Post Date:
2019-09-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-25
Last Update Post Date:
2019-09-26
Last Update Post Date Type:
ACTUAL